DA Davidson analyst Kevin Fitzsimmons downgrades Southern First Bancshares (NASDAQ:SFST) from Buy to Neutral and lowers the price target from $52 to $50.
Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System
Autolus Therapeutics plc (NASDAQ:AUTL) has entered into an agreement with Bristol-Myers Squibb Co (NYSE:BMY). The agreement grants Bristol Myers Squibb access to incorporate Autolus’…
